The Guinea-pig Distal Colon--a Sensitive Preparation for the Investigation of 5-HT4 Receptor-mediated Contractions

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1993 Dec 1

PMID 8306106

Citations 19

Authors

K A Wardle

G J Sanger

Affiliations

Soon will be listed here.

Abstract

1. Experiments were designed to characterize pharmacologically the contractile responses to 5-hydroxytryptamine (5-HT) in the guinea-pig isolated distal colon longitudinal muscle-myenteric plexus preparation (LMMP). 2. In the presence of methiothepin (100 nM) and granisetron (1 microM), 5-HT (10 pM-10 nM) produced concentration-dependent contractile responses of the guinea-pig distal colon LMMP, with a pEC50 of 9.2 +/- 0.08. 3. Responses to 5-HT were mimicked by a series of tryptamine analogues, with the following rank order of potency; 5-HT > 5-MeOT >> 5-CT > tryptamine > 2-Me-5-HT. All were found to be full agonists. 4. Responses to 5-HT were also mimicked by a series of substituted benzamide analogues. Their rank order of potency was 5-HT > renzapride > cisapride > (S)-zacopride > (R)-zacopride > metoclopramide. All were full agonists relative to 5-HT. 5. The benzimidazolone derivatives, BIMU 1 and BIMU 8 were approximately equipotent partial agonists (intrinsic activities of 0.8 +/- 0.07 and 0.5 +/- 0.08 respectively) in the guinea-pig distal colon. 6. Tropisetron produced a rightward displacement of the 5-HT concentration-effect curve, yielding an apparent pA2 of 6.4 +/- 0.1. The slope of the Schild plot (1.3 +/- 0.1) was significantly greater than unity. 7. SDZ 205,557 produced a concentration-dependent shift to the right of the 5-HT concentration-response curve, yielding an estimated pA2 of 7.8 +/- 0.1 and a slope which did not significantly deviate from unity. SDZ 205 557 produced similar pKB estimates (7.3-7.9) when tested against 5-MeOT,renzapride and 5-CT, indicating a common site of action.8. The pharmacological profile of the 5-HT-evoked contractions of the guinea-pig distal colon LMMPare consistent with activity at the 5-HT4 receptor. Furthermore, of the models of this receptor described in the literature, the guinea-pig distal colon appears to be the most sensitive model to date, making it a useful tool in the investigation of 5-HT4 receptor-mediated events.

Citing Articles

Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders.

Tack J, Camilleri M, Chang L, Chey W, Galligan J, Lacy B Aliment Pharmacol Ther. 2012; 35(7):745-67.

PMID: 22356640 PMC: 3491670. DOI: 10.1111/j.1365-2036.2012.05011.x.

Serotonin pharmacology in the gastrointestinal tract: a review.

Beattie D, Smith J Naunyn Schmiedebergs Arch Pharmacol. 2008; 377(3):181-203.

PMID: 18398601 DOI: 10.1007/s00210-008-0276-9.

Pharmacology and metabolism of renzapride : a novel therapeutic agent for the potential treatment of irritable bowel syndrome.

Meyers N, Hickling R Drugs R D. 2007; 9(1):37-63.

PMID: 18095752 PMC: 7044400. DOI: 10.2165/00126839-200809010-00004.

A comparison of the pharmacological properties of guinea-pig and human recombinant 5-HT4 receptors.

Vickery R, Mai N, Kaufman E, Beattie D, Pulido-Rios T, OKeefe M Br J Pharmacol. 2007; 150(6):782-91.

PMID: 17293885 PMC: 2013860. DOI: 10.1038/sj.bjp.0707154.

Effects of dexfenfluramine on serotonin levels of mice ileum, contractility, glutathione and malondialdehyde level.

Ozer C, Gonul B, Elmas C, Erdouan D, Ercan Z Mol Cell Biochem. 2005; 280(1-2):151-7.

PMID: 16311917 DOI: 10.1007/s11010-005-8842-7.

References

Dumuis A, Bouhelal R, Sebben M, Cory R, Bockaert J . A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol. 1988; 34(6):880-7. View

Dumuis A, Sebben M, Bockaert J . The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons. Naunyn Schmiedebergs Arch Pharmacol. 1989; 340(4):403-10. DOI: 10.1007/BF00167041. View

Idres S, Delarue C, Lefebvre H, Vaudry H . Benzamide derivatives provide evidence for the involvement of a 5-HT4 receptor type in the mechanism of action of serotonin in frog adrenocortical cells. Brain Res Mol Brain Res. 1991; 10(3):251-8. DOI: 10.1016/0169-328x(91)90068-9. View

Dumuis A, Bouhelal R, Sebben M, Bockaert J . A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930. Eur J Pharmacol. 1988; 146(1):187-8. DOI: 10.1016/0014-2999(88)90503-1. View

Buchheit K, Gamse R, Pfannkuche H . SDZ 205-557, a selective antagonist at 5-HT4 receptors in the isolated guinea pig ileum. Eur J Pharmacol. 1991; 200(2-3):373-4. DOI: 10.1016/0014-2999(91)90601-l. View

ARUNLAKSHANA O, SCHILD H . Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959; 14(1):48-58. PMC: 1481829. DOI: 10.1111/j.1476-5381.1959.tb00928.x. View

Villalon C, Den Boer M, Heiligers J, Saxena P . Mediation of 5-hydroxytryptamine-induced tachycardia in the pig by the putative 5-HT4 receptor. Br J Pharmacol. 1990; 100(4):665-7. PMC: 1917582. DOI: 10.1111/j.1476-5381.1990.tb14073.x. View

Grossman C, Kilpatrick G, Bunce K . Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain. Br J Pharmacol. 1993; 109(3):618-24. PMC: 2175660. DOI: 10.1111/j.1476-5381.1993.tb13617.x. View

Parker R, WAUD D . Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. J Pharmacol Exp Ther. 1971; 177(1):1-12. View

10.

Handschumacher R, Vane J . The relationship between the penetration of tryptamine and 5-hydroxytryptamine into smooth muscle and the associated contractions. Br J Pharmacol Chemother. 2008; 29(1):105-18. PMC: 1557177. DOI: 10.1111/j.1476-5381.1967.tb01944.x. View

11.

Baxter G, Clarke D . Benzimidazolone derivatives act as 5-HT4 receptor ligands in rat oesophagus. Eur J Pharmacol. 1992; 212(2-3):225-9. DOI: 10.1016/0014-2999(92)90333-y. View

12.

Dumuis A, Sebben M, MONFERINI E, Nicola M, Turconi M, Ladinsky H . Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in brain. Naunyn Schmiedebergs Arch Pharmacol. 1991; 343(3):245-51. DOI: 10.1007/BF00251122. View

13.

Craig D, Clarke D . Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine receptor. J Pharmacol Exp Ther. 1990; 252(3):1378-86. View

14.

Sanger G . Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924. Br J Pharmacol. 1987; 91(1):77-87. PMC: 1853491. DOI: 10.1111/j.1476-5381.1987.tb08985.x. View

15.

Kaumann A, Sanders L, Brown A, Murray K, Brown M . A 5-hydroxytryptamine receptor in human atrium. Br J Pharmacol. 1990; 100(4):879-85. PMC: 1917575. DOI: 10.1111/j.1476-5381.1990.tb14108.x. View

16.

Buchheit K, Engel G, Mutschler E, Richardson B . Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea-pig ileum. Evidence for two distinct release mechanisms. Naunyn Schmiedebergs Arch Pharmacol. 1985; 329(1):36-41. DOI: 10.1007/BF00695189. View

17.

Penttila A . Distribution and intensity of monoamine oxidase activity in the mammalian duodenum. Acta Physiol Scand. 1968; 73(1):121-7. DOI: 10.1111/j.1748-1716.1968.tb04089.x. View

18.

Sanger G, Nelson D . Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron). Eur J Pharmacol. 1989; 159(2):113-24. DOI: 10.1016/0014-2999(89)90695-x. View

19.

Lefebvre H, Contesse V, Delarue C, Feuilloley M, Hery F, Grise P . Serotonin-induced stimulation of cortisol secretion from human adrenocortical tissue is mediated through activation of a serotonin4 receptor subtype. Neuroscience. 1992; 47(4):999-1007. DOI: 10.1016/0306-4522(92)90047-6. View

20.

Lorrain J, Grosset A, OConnor S . 5-HT4 receptors, present in piglet atria and sensitive to SDZ 205-557, are absent in papillary muscle. Eur J Pharmacol. 1992; 229(1):105-8. DOI: 10.1016/0014-2999(92)90293-d. View